{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:34:56Z","timestamp":1787927696259,"version":"build-2784847793"},"reference-count":12,"publisher":"Georg Thieme Verlag KG","issue":"01","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":1597,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Nucl Med"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>Amyloid positron emission tomography (PET) imaging with florbetapir 18F (18F-AV-45) allows in vivo assessment of cerebral amyloid load and can be used in the evaluation of progression of Alzheimer's disease (AD) and other dementias associated with b-amyloid. However, cortical amyloid deposition can occur in healthy cases, as well as in patients with AD and quantification of cortical amyloid burden can improve the 18F-AV-45 PET imaging evaluations. The quantification is mostly performed by cortical-to-cerebellum standardized uptake value ratio (SUVr). The aim of our study was to compare two methods for SUVr calculations in amyloid florbetapir 18F PET brain imaging. In amyloid florbetapir 18F PET brain imaging study, we imaged 42 cases with the mean age of 72.6 \u00b1 9.9 (mean \u00b1 standard deviation). They were imaged on different PET\/computed tomography systems with 369.0 \u00b1 34.2 kBq of 18F florbetapir. Data were reconstructed using the vendor's reconstruction software. Corresponding magnetic resonance imaging (MRI) data were retrieved, and matched PET and MRI data were transferred to a common platform. Two methods were used for the calculation of the ratio of cortical-to-cerebellar signal (SUVr). One method was based on the MIM Software Inc., Version 6.4 software and only uses PET data. The second approach used the PMOD Neuro tool (version 3.5). This approach utilizes PET and corresponding MRI data (preferably T1-weighted) for better brain segmentation. For all the 42 cases, the average SUVr values for MIM and PMOD applications were 1.24 \u00b1 0.26 and 1.22 \u00b1 0.25, respectively, with a mean difference of 0.02 \u00b1 0.15. The repeatability coefficient was 0.15 (12.3% of the mean). The Spearman's rank correlation coefficient was very high, r = 0.96. For amyloid-negative cases, the average SUVr values were lower than all group SUVr average values, 0.96 \u00b1 0.07 and 1.00 \u00b1 0.09, for MIM and PMOD applications, respectively. A mean difference was 0.04 \u00b1 0.12, the repeatability coefficient was 0.12 (12.9% of the mean) and the Spearman's rank correlation coefficient was modest, r = 0.55. For amyloid-positive patients, the average SUVr values were higher than the same all grouP values, 1.34 \u00b1 0.16 and 1.35 \u00b1 0.20, respectively, with a mean difference of 0.01 \u00b1 0.16. The repeatability coefficient was 0.16 (11.9% of the mean). The Spearman's rank correlation coefficient was high, r = 0.93. Our results indicated that the SUVr values derived using MIM and PMOD Neuro are effectively interchangeable and well correlated. However, PET template-based quantification (MIM approach) is clinically friendlier and easier to use. MRI template-based quantification (PMOD Neuro) better delineates different regions of the brain, can be used with any tracer, and therefore is more suitable for research.<\/jats:p>","DOI":"10.4103\/wjnm.wjnm_5_17","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T05:24:13Z","timestamp":1515129853000},"page":"21-26","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of standardized uptake value ratio calculations in amyloid positron emission tomography brain imaging"],"prefix":"10.1055","volume":"17","author":[{"given":"Karin","family":"Knesaurek","sequence":"additional","affiliation":[{"name":"Department of Radiology, Division of Nuclear Medicine, Icahn School of Medicine at Mount Sinai, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Warnock","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Kostakoglu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Division of Nuclear Medicine, Icahn School of Medicine at Mount Sinai, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrill","family":"Burger","sequence":"additional","affiliation":[{"name":"PMOD Technologies LLC, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for Alzheimer\u2032s Disease","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"key-10.4103\/1450-1147.222285-1","first-page":"306","volume-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"key-10.4103\/1450-1147.222285-2","first-page":"1733","volume-title":"Brain amyloid imaging","author":"Rowe","year":"2011","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.222285-3","first-page":"913","volume-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","author":"Wong","year":"2010","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.222285-4","first-page":"669","volume-title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u00df plaques: A prospective cohort study","author":"Clark","year":"2012","journal-title":"Lancet Neurol"},{"key":"key-10.4103\/1450-1147.222285-5","first-page":"378","volume-title":"Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer's disease and cognitively normal subjects","author":"Joshi","year":"2012","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.222285-6","first-page":"275","volume-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"key-10.4103\/1450-1147.222285-7","first-page":"273","volume-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"key-10.4103\/1450-1147.222285-8","unstructured":"User's Guide PMOD Neuro Tool. Available from: http:\/\/www.pmod.com\/files\/download\/v35\/doc\/PDF\/PNEURO.pdf. [Last accessed on 2017 Jan 27]."},{"key":"key-10.4103\/1450-1147.222285-9","first-page":"709","volume-title":"A new biometrical procedure for testing the equality of measurements from two different analytical methods.Application of linear regression procedures for method comparison studies in clinical chemistry, Part I","author":"Passing","year":"1983","journal-title":"J Clin Chem Clin Biochem"},{"key":"key-10.4103\/1450-1147.222285-10","first-page":"307","volume-title":"Statistical methods for assessing agreement between two methods of clinical measurement","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"key-10.4103\/1450-1147.222285-11","unstructured":"Precision of Test Methods. I: Guide for the Determination and Reproducibility for a Standard Test Method. London, U.K.: British Standards Institution; 1976. p. 54-97."},{"key":"key-10.4103\/1450-1147.222285-12","first-page":"836","volume-title":"Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo","author":"Saint-Aubert","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["World Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.4103\/wjnm.WJNM_5_17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T18:56:03Z","timestamp":1652813763000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.4103\/wjnm.WJNM_5_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":12,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2022,5,17]]},"published-print":{"date-parts":[[2018,1]]}},"URL":"https:\/\/doi.org\/10.4103\/wjnm.wjnm_5_17","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1450-1147","1607-3312"],"issn-type":[{"value":"1450-1147","type":"print"},{"value":"1607-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}